Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain

Nitric oxide (NO)/cyclic guanosine 3′,5′-monophosphate (cGMP) signaling has been shown to act as a mediator involved in pain transmission and processing. In this review, we summarize and discuss the mechanisms of the NO/cGMP signaling pathway involved in chronic pain, including neuropathic pain, bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan-Yang, Gao, Shao-Jie, Sun, Jia, Zhang, Long-Qing, Wu, Jia-Yi, Song, Fan-He, Liu, Dai-Qiang, Zhou, Ya-Qun, Mei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827765/
https://www.ncbi.nlm.nih.gov/pubmed/36254980
http://dx.doi.org/10.4103/1673-5374.355748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827765/
https://www.ncbi.nlm.nih.gov/pubmed/36254980
http://dx.doi.org/10.4103/1673-5374.355748

Ejemplares similares